View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Uncategorised
December 30, 2021

Coronavirus company news summary – Merck to build flow membrane production facility – FDA grants EUA for Siemens Healthineers’ Covid-19 test

By Srivani Venna

Merck’s Life Science business sector has secured a contract award worth €121m from the US Department of Defense (DoD) to construct a lateral flow membrane production facility at the company’s site in Sheboygan, Wisconsin. The new facility will produce the company’s Hi-Flow Plus lateral flow membrane, which is used in rapid diagnostic test kit manufacturing, including Covid-19. The contract awarded on behalf of the US Department of Health and Human Services, will help ensure secure supply and production capacity locally for critical products to prepare for the pandemic.

The US Food and Drug Administration (FDA) has granted emergency use authorization (EUA) for Siemens Healthineers’ CLINITEST Rapid COVID-19 Antigen Self-Test. The easy-to-use nasal swab test, which is expected to be available beginning January next year, will help to rapidly detect the SARS-CoV-2 virus and can provide visually read test results in just 15 minutes. It will be made broadly available through nationwide retail distribution. The FDA authorisation will give access to a new at-home or over-the-counter self-test in the country as testing needs for Covid-19 continue to increase.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Medical Device Network